Harnessing the Power of Preclinical NASH Models to Strategically Predict & Improve Clinical Outcomes & Therapeutic Response

Time: 11:00 am
day: Day 1 Stream 2 AM


• Highlighting preclinical rodent models of NASH and liver fibrosis, and ex vivo/in vitro systems modeling aspects of NASH/fibrosis.
• Illustrating predictive capacity of preclinical models/systems to clinical efficacy by discussing ACC inhibitor/FXR agonism combination approach. • Investigating how to optimize preclinical NASH model use to strategically achieve a positive therapeutic response